FDA Approves Clinical Trials of Novel Therapy for PVD

The FDA has approved Phase 1 first in man clinical trials of Natural Vascular Scaffolding (NVS) therapy, a novel drug/device combination for the treatment of peripheral vascular disease (PVD).